Duncan Moore Ph.D Overview

  • Primary Position
  • Partner

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 3

  • Med. Deal Size

  • Med. Valuation

Duncan Moore Ph.D General Information

Biography

Dr. Duncan Moore serves as Partner at East West Capital Partners. He also serves as Executive Chairman at Lamellar Biomedical. He serves as Board Member at ASP Isotopes, GH Research, Cycle pharma, and Forward Pharma. He is an Angel Investor. He served as Senior Advisor at Hadean Ventures. He is currently a partner at East West Capital. He served as Deputy Chairman at Braidlock. Prior to that, he was a Managing Director at Morgan Stanley where he was the global head of healthcare research. During this time he led the equity market positioning of a number of major healthcare companies including Wellcome, Sulzer Medica, Almirall, and Grupo Rovi. He served as a Chairman at StepJockey. He trained as a biochemist at the University of Leeds and has a Ph.D. from the University of Cambridge. Whilst at Cambridge he co-founded a molecular diagnostics company with 2 colleagues. Following his move to the capital market in 1985, he was involved in setting up the bankInvest BioVenture funds and sat on the board of these funds until they were sold in 2009.

Contact Information

Primary Position
Partner, East West Capital Partners
Education
University of Cambridge, Ph.D. (Doctor of Philosophy)
University of Leeds, BS (Bachelor of Science)
University of Cambridge, M.Phil (Master of Philosophy)
Gender
Male
Total Investments
Exits
Email
du
Address
  • London
  • England, United Kingdom

Duncan Moore Ph.D Positions (1)

Firm name Firm type Title Location Industry Since
East West Capital Partners Investor Partner Singapore, Singapore Venture Capital

Duncan Moore Ph.D Board Seats (4)

Company Industry Ownership Status Financing Status Location Since
ASP Isotopes Industrial Chemicals Publicly Held Corporation Washington, DC
Cycle pharma Pharmaceuticals Privately Held (no backing) Corporation Cambridge, United Kingdom
GH Research Drug Discovery Publicly Held Formerly VC-backed Dublin, Ireland
Lamellar Biomedical Therapeutic Devices Out of Business Formerly VC-backed Holytown, United Kingdom

Duncan Moore Ph.D Lead Partner on Deals (5)

Duncan Moore Ph.D has been the lead partner on 5 deals. Their latest deal was with Klydon Proprietary (Intellectual Property Assets and Interest in Four entities), a buildings and property company. The deal was made on 04-Apr-2023.

Company Deal Date Deal Type Deal Size Deal Status Industry Location
Klydon Proprietary (Intellectual Property Assets and Interest in Four entities) 04-Apr-2023 Corporate Asset Purchase Completed Buildings and Property Pretoria, South Africa
StepJockey 13-Sep-2015 Completed Other Healthcare Technology Systems London, United Kingdom
Braidlock 01-Nov-2013 Completed Medical Supplies Warrington, United Kingdom
Lamellar Biomedical 06-Dec-2012 Later Stage VC (Series A) Completed Therapeutic Devices Holytown, United Kingdom
LiPlasome Pharma 01-Mar-2005 Early Stage VC (Series B) Completed Drug Delivery Horsholm, Denmark

Duncan Moore Ph.D Network (57)

Board Members (36)

Name Company Representing Location From
Gail Maderis Allarity Therapeutics Self Boston, MA
Matthew Jameson Evans StepJockey Self London, United Kingdom
StepJockey StepJockey London, United Kingdom
Lamellar Biomedical Self Holytown, United Kingdom
Forward Pharma Rosetta Capital (UK) Hellerup, Denmark

Portfolio Executives (21)

Name Company Role Deal date Location
Richard Smith StepJockey Account Director 13-Sep-2015 London, United Kingdom
Helen Nuki StepJockey Co-Founder & Board Member 13-Sep-2015 London, United Kingdom
StepJockey Partnerships Director 13-Sep-2015 London, United Kingdom
StepJockey Director & Project Manager 13-Sep-2015 London, United Kingdom
StepJockey Co-Founder, Board Member & Chief Executive Officer 13-Sep-2015 London, United Kingdom

Duncan Moore Ph.D FAQs

  • Who is Duncan Moore Ph.D?

    Dr. Duncan Moore serves as Partner at East West Capital Partners.

  • How much does Duncan Moore Ph.D typically invest?

    Duncan Moore Ph.D's median deal size is .

  • What is Duncan Moore Ph.D’s main position?

    Duncan Moore Ph.D’s primary position is Partner.

  • How many active board seats does Duncan Moore Ph.D hold?

    Duncan Moore Ph.D holds 4 board seats including ASP Isotopes, Cycle pharma, GH Research, and Lamellar Biomedical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »